Stay updated on Pediatric Upadacitinib Pharmacokinetics in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Pediatric Upadacitinib Pharmacokinetics in Atopic Dermatitis Clinical Trial page.

Latest updates to the Pediatric Upadacitinib Pharmacokinetics in Atopic Dermatitis Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page now displays a minor revision label (v3.4.2) replacing the previous v3.4.1; no study content, eligibility criteria, or locations are changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check20 days agoChange DetectedThe page footer shows a revision update from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check27 days agoChange DetectedAdded UI elements and metadata label changes, including a glossary toggle (Show glossary) and updates to QC-related fields such as Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0, while removing the older labels Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedA minor metadata update shows Revision: v3.3.4 added and Revision: v3.3.3 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedA new Locations section lists study sites across multiple U.S. states and Hordaland, Norway. The revision tag updated to v3.3.3.SummaryDifference1%

- Check91 days agoChange DetectedThe changes involve slight wording adjustments to the Publications From PubMed note and the revision version in the page footer, which are minor metadata updates and do not alter the study details or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pediatric Upadacitinib Pharmacokinetics in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Upadacitinib Pharmacokinetics in Atopic Dermatitis Clinical Trial page.